Delivery Order SPE2DB20D3505-SPE2DB24FT3P8
Award Date
11/16/23
Potential Completion Date
11/17/23
Potential Value
$8.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DX15D7067|SPE2DX23F1QAF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $7,717.47 and is a Firm Fixed Price Delivery Order with a completion date of May 2, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a...
This federal contract award, with ID SPE2DB20D3303|SPE2DB24FY1X1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,816.73 and an ultimate completion date of October 30, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on October...
This federal contract award, with an ID of SPE2DB22D2005|SPE2DB24FJFM4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $2,025.19 and an ultimate completion date of December 14, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The award is a Firm Fixed Price Delivery Order with a ceiling value of $15,172.54 and a completion date of November 2, 2021. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, valued at $3,677.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563217759 units of Ondansetron ODT 4 mg tablets, which are used to treat nausea and vomiting. This is a firm-fixed-price delivery order contract with a completion date of January 4, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,693.66 firm-fixed-price delivery order is for the supply of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has an ultimate completion date of October 12, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM5K9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567116736 units of Ondansetron ODT 4 mg tablets, a pharmaceutical product used for the treatment of nausea and vomiting. The award has a ceiling value of $5,975.16 and is a firm fixed-price delivery order contract, with a completion date of February 3, 2025. The contract does not have a...
This federal contract award, valued at $30,017.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a prescription medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 8, 2023 and is a Firm Fixed Price Delivery Order. The contract was awarded on December 7, 2022 without any set-aside designation, indicating open...
This federal contract award, valued at $4,175.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has an ultimate completion date of December 8, 2023 and is a firm fixed-price delivery order. This award is not associated with a set-aside program and was made through full and open competition....
This federal contract award (SPE2DB20D1109|SPE2DB24FN04W) was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a ceiling value of $11,854.86 and an ultimate completion date of November 9, 2023. It is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA...